NAGE FY 2019 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$393M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$46M+46.7% YoY

Gross Profit

$26M55.7% margin

Operating Income

-$31M-67.6% margin

Net Income

-$32M-69.4% margin

EPS (Diluted)

$-0.56

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$21M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$40M

Total Liabilities

$20M

Stockholders' Equity

$20M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$46M	$32M	+46.7%
Gross Profit	$26M	$16M	+60.5%
Operating Income	-$31M	-$33M	+5.6%
Net Income	-$32M	-$33M	+3.5%